register

News & Trends - MedTech & Diagnostics

AI integration in insertable cardiac monitors to save clinics 180+ hours

Health Industry Hub | May 20, 2024 |

MedTech & Diagnostics News: Medtronic has leveraged the power of artificial intelligence (AI) to enhance its Reveal Linq insertable cardiac monitor (ICM) devices with a cloud-based update. This upgrade has been implemented across Australia, New Zealand, and the United States.

The newly integrated AccuRhythm AI deploys deep learning algorithms seamlessly integrated into the CareLink network, effectively eliminating false atrial fibrillation (AF) and pause episodes.

The platform utilises a vast database comprising over 1 million electrocardiogram heart rhythm episodes. Notably, these enhancements are automatically applied in the cloud, requiring no action from patients.

Projections from Medtronic indicate that the incorporation of these AI algorithms will yield an 85% reduction in false AF and pause alerts. Furthermore, the company anticipates maintaining a high level of accuracy, with true alerts preserved at rates of 98.2% for AF and 99.9% for pause incidents.

As a result, clinics stand to benefit significantly, saving over 186 hours annually in false alert review for every 200 Reveal Linq patients. This efficiency grants clinicians additional time to dedicate to critical patient care activities.

Stacey Churchwell, Vice President and General Manager of Cardiovascular Diagnostics and Services at Medtronic, reflected on this milestone, stating, “This milestone is both a nod to the past as we celebrate the thousands of patients who have benefited from Reveal LINQ over the last decade, and a glimpse into the future as an example of how AI can effectively update an established technology overnight.”

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the ONLY one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The exclusive leadership and influencer podcasts and vodcasts add huge value to our breaking news coverage. The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - Pharmaceuticals

Clinicians unveil Novartis and BMS practice-changing trial results

Clinicians unveil Novartis and BMS practice-changing trial results

Health Industry Hub | June 24, 2024 |

Pharma News: Australia, known for its alarming melanoma rates, witnesses one person diagnosed with the disease every 30 minutes, and […]

More


News & Trends - Pharmaceuticals

Hearts4heart leads awareness week, amid progress in Boehringer Ingelheim and AstraZeneca therapies

Hearts4heart leads awareness week, amid progress in Boehringer Ingelheim and AstraZeneca therapies

Health Industry Hub | June 24, 2024 |

Pharma News: Heart failure is a significant health concern in Australia, affecting approximately half a million people, with over 67,000 […]

More


News & Trends - MedTech & Diagnostics

Cardiologists mark Australian first with Boston Scientific's intracoronary imaging system

Cardiologists mark Australian first with Boston Scientific’s intracoronary imaging system

Health Industry Hub | June 24, 2024 |

MedTech & Diagnostics News: Percutaneous coronary intervention (PCI) has faced substantial complications and failure rates, despite advances in medical devices […]

More


Leadership & Management

AbbVie New Zealand welcomes new leadership amid global moves

AbbVie New Zealand welcomes new leadership amid global moves

Health Industry Hub | June 24, 2024 |

Leadership & Management: In line with its global talent development plan, AbbVie has announced a significant change in leadership for […]

More


This content is copyright protected. Please subscribe to gain access.